SCYNEXIS Inc (SCYX) Down 0.92% in Premarket Trading

SCYNEXIS Inc (SCYX) is down Tuesday morning, with the stock falling -0.92% in pre-market trading to 2.16. SCYX's short-term technical score of 25 indicates that the stock has traded less bullishly over the last month than 75% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 130 out of 146 industries, SCYNEXIS Inc ranks higher than 39% of stocks. SCYNEXIS Inc has fallen 27.57% over the past month, closing at $3.47 on August 29. During this period of time, the stock fell as low as $2.18 and as high as $3.87. SCYX has an average analyst recommendation of Strong Buy. The company has an average price target of $11.80.

SCYX has an Overall Score of 52. Find out what this means to you and get the rest of the rankings on SCYX!

See Full SCYX Report

SCYNEXIS Inc has a Long-Term Technical rank of 57. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 43% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 68 by this metric, SCYX ranks better than 68% of stocks.

Important Dates for Investors in SCYX:

-SCYNEXIS Inc is set to release earnings on 2023-11-08. Over the last 12 months, the company has reported EPS of $0.77. -We do not have a set dividend date for SCYNEXIS Inc at this time. Click Here To Get The Full Report on SCYNEXIS Inc (SCYX)